GPS Participações e Empreendimentos S.A. (GGPS3) Q1 2025 earnings summary

Executive summary

• Net revenue reached R$4,104 million in 1Q25, up 34% year-over-year, with 5% organic growth and significant contributions from recent acquisitions, notably GRSA, RHMed, and Nutricar, which will impact results from 2Q25 onward.

• Adjusted EBITDA ex-IFRS16 was R$401 million, up 21% year-over-year, with a margin of 9.8%, slightly below the previous year due to integration costs and wage adjustments.

• Adjusted net income was R$180 million, 7% higher year-over-year, with a net margin of 4.4%, impacted by higher financial expenses and integration costs.

• Integration of GRSA, the largest acquisition to date, was completed, with further acquisitions (RHMed, Nutricar) to impact results from 2Q25.

• Customer base remains diversified, with 4,604 clients and over 183,000 employees nationwide.

Financial highlights

• Net revenue grew 34% year-over-year to R$4,104 million, with organic revenue up 5% and M&A-driven revenue up 632%.

• Adjusted EBITDA ex-IFRS16 rose 21% to R$401 million, but margin declined by 1 p.p. to 9.8% due to integration costs and salary adjustments.

• Adjusted net income increased 7% to R$180 million, with net margin down 1.1 p.p. to 4.4%.

• Cash generation from operations was R$374 million, representing 93% of adjusted EBITDA.

• Net debt/adjusted EBITDA ex-IFRS16 was 1.6x at 1Q25, up from 1.3x in 1Q24, reflecting acquisition investments.

Outlook and guidance

• 2025 expected to be challenging due to GRSA integration and competitive pressures on organic growth.

• Focus remains on balancing profitability with new contract acquisition and maintaining margins.

• Most GRSA synergies to be implemented in Q2 and the second half of the year.

• Organic growth expected to improve as commercial activities intensify and macrostructure changes take effect.

• Labor-related expenses expected to show improvement by year-end, with full normalization targeted for 2026.